Evidence map›Paper›PMID 34505368›Full record

ArticleWorld psychiatry : official journal of the World Psychiatric Association (WPA)2021

Repetitive transcranial magnetic stimulation for smoking cessation: a pivotal multicenter double-blind randomized controlled trial.

Abraham Zangen, Hagar Moshe, Diana Martinez, Noam Barnea-Ygael, Tanya Vapnik, Alexander Bystritsky, Walter Duffy, Doron Toder, Leah Casuto, Moran Lipkinsky Grosz and 13 more

2 registry-linked trialsOpen access · bronzeAbstract read
In one paragraph

Article in World psychiatry : official journal of the World Psychiatric Association (WPA), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 119 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
119citing papers in PubMed, 3 pooled it
13.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02126124 phase3completednot on this map

A Prospective, Double Blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of the Deep Transcranial Magnetic Stimulation (DTMS) (With the H-ADD Coil) Intended as an Aid to Smoking Cessation.

TypeinterventionalSponsorBrainswayRan2014 to 2019Enrolled224ConditionsSmoking CessationArmsSham Treatment, Active dTMS Treatment
NCT06346028 phase4recruitingnot on this mapstarted 2024, after this paper: background citation

A Pragmatic Feasibility Trial on the Implementation of Transcranial Magnetic Stimulation for Smoking Cessation

TypeinterventionalSponsorCentre for Addiction and Mental HealthRan2024 to 2028Enrolled40ConditionsSmokingArmsBrainsway H4 deep rTMS coil and Brainsway stimulator system
3 · Its place in the literature

Who cites it

119 citing papers in PubMed, 3 syntheses or guidelines pooled it, 220 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Comparing neuromodulation targets to reduce cigarette craving and withdrawal: a randomized clinical trial.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Trial
  7. Perceptual and Cognitive Effects of Focal Transcranial Direct Current Stimulation of Auditory Cortex in Tinnitus.Neuromodulation : journal of the International Neuromodulation Society · 2025
    Trial
  8. Trial
  9. Focal tDCS of auditory cortex in chronic tinnitus: A randomized controlled mechanistic trial.Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology · 2024
    Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Article
  16. Review
  17. Article
  18. Article
  19. Addiction biology · 2026
    Article
  20. Article

59 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 18 institutions in 2 countries.

Abraham ZangenDepartment of Life Sciences and Zlotowski Centre for Neuroscience, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Hagar MosheDepartment of Life Sciences and Zlotowski Centre for Neuroscience, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Diana MartinezDepartment of Psychiatry, Columbia University Irving Medical Center, New York, NY, USA.
Noam Barnea-YgaelDepartment of Life Sciences and Zlotowski Centre for Neuroscience, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Tanya VapnikPacific Institute of Medical Research, Los Angeles, CA, USA.
Alexander BystritskyPacific Institute of Medical Research, Los Angeles, CA, USA.
Walter DuffyAlivation Health, Lincoln, NE, USA.
Doron ToderDepartment of Life Sciences and Zlotowski Centre for Neuroscience, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Leah CasutoLindner Center of HOPE, and University of Cincinnati Department of Psychiatry and Behavioral Medicine, Cincinnati, OH, USA.
Moran Lipkinsky GroszTel Aviv University Medical School, Tel Aviv and Be'er Yaacov Mental Health Center, Be'er Yaacov, Israel.
Edward V NunesDepartment of Psychiatry, Columbia University Irving Medical Center, New York, NY, USA.
Herbert WardDepartment of Psychiatry, University of Florida College of Medicine, Gainesville, FL, USA.
Aron TendlerAdvanced Mental Health Care Inc., Royal Palm Beach, FL, USA.
David FeifelKadima Neuropsychiatry Institute, La Jolla, CA, USA.
Oscar MoralesHarvard Medical School, McLean Hospital, Belmont, MA, USA.
Yiftach RothDepartment of Life Sciences and Zlotowski Centre for Neuroscience, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Dan V IosifescuNew York University School of Medicine and Nathan Kline Institute, New York, NY, USA.
Jaron WinstonSenior Adults Specialty Research, Austin, TX, USA.
Theodore WireckiTMS Center of Colorado, Lakewood, CO, USA.
Ahava SteinA. Stein - Regulatory Affairs Consulting Ltd., Kfar Saba, Israel.
Frederic DeutschBiostatistical Consulting, BioStats, Modiin-Maccabim-Reut, Israel.
Xingbao LiBrain Stimulation Division, Psychiatry, Medical University of South Carolina, Charleston, SC, USA.
Mark S GeorgeBrain Stimulation Division, Psychiatry, Medical University of South Carolina, Charleston, SC, USA.
Ben-Gurion University of the Negev · ILCalifornia Pacific Medical Center · USColumbia University Irving Medical Center · USAdvanced Mental Health Care · USAlivation (United States) · USBiostatistical Consulting (United States) · USColorado Christian University · USMcLean Hospital · USMedical University of South Carolina · USMuseum of Contemporary Art San Diego · USNew York University · USRalph H. Johnson VA Medical Center · USSpecialty Materials (United States) · USTel Aviv University · ILThe Technological College of Beer Sheva · ILUniversity of Cincinnati · USUniversity of Florida · USWestern Digital (Israel) · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive brain stimulation method increasingly used to treat psychiatric disorders, primarily depression. Initial studies suggest that rTMS may help to treat addictions, but evaluation in multicenter randomized controlled trials (RCTs) is needed. We conducted a multicenter double-blind RCT in 262 chronic smokers meeting DSM-5 criteria for tobacco use disorder, who had made at least one prior failed attempt to quit, with 68% having made at least three failed attempts. They received three weeks of daily bilat-eral active or sham rTMS to the lateral prefrontal and insular cortices, followed by once weekly rTMS for three weeks. Each rTMS session was administered following a cue-induced craving procedure, and participants were monitored for a total of six weeks. Those in abstinence were monitored for additional 12 weeks. The primary outcome measure was the four-week continuous quit rate (CQR) until Week 18 in the intent-to-treat efficacy set, as determined by daily smoking diaries and verified by urine cotinine measures. The trial was registered at ClinicalTrials.gov (NCT02126124). In the intent-to-treat analysis set (N=234), the CQR until Week 18 was 19.4% following active and 8.7% following sham rTMS (X

Indexed as

addiction medicinecigarette consumptioncigarette cravinginsulalateral prefrontal cortexrepetitive transcranial magnetic stimulationSmoking cessation

Identifiers

PMID34505368
PMCPMC8429333
OpenAlexW3197696608

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.